156 results
Page 3 of 8
DEFA14A
xlg4nh316o j713o
29 Aug 12
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
561jqoealduub 5fyt
27 Aug 12
Regulation FD Disclosure
12:00am
8-K
EX-99.1
l1z 8r3i1l9kbjbdps12
8 Aug 12
Cell Therapeutics Announces Planned Reverse Stock Split
12:00am
8-K
EX-99.1
jkhg66zxxst3
1 Aug 12
Launch and Start of Pacritinib Phase 3 Trial; Reports Second
12:00am
8-K
EX-99.1
m5k47lk3p0em1qql
5 Jun 12
Cell Therapeutics Completes Acquisition of Pacritinib a Highly Selective JAK2 Inhibitor
12:00am
8-K
EX-10.1
3336r
24 Apr 12
Cell Therapeutics Enters into Agreement to
12:00am
8-K
EX-99.1
q3zpnqb33qi6k26
27 May 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
xa2v g7ghl8j60o2
6 May 11
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
EX-99.1
fgxm 6d7jafiems
9 Apr 10
Regulation FD Disclosure
12:00am
8-K
EX-99.1
fppgl
30 Sep 09
Regulation FD Disclosure
12:00am